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Abstract
Doxorubicin-induced cardiomyopathy is a clinically prevalent pathology, occurring as a se-
quelae following chemotherapy for cancer patients. In particular, the “ﬁrst dose” effect
has been particularly challenging, given the heterogeneous and multifactorial nature of
this pathophysiology. Here, we describe the development of a physiologically relevant
in vitro model for cardiotoxicity testing, using human cells. Primary cardiomyocytes, endo-
thelial, and smooth muscle cells were tri-cultured in 2D, or within nano-ﬁbrous scaffolds in
a 3D environment, under dynamic nutrient ﬂow, using the Quasi Vivo® system. State-of-
the-art sensor chips were used to detect troponin I levels, 2 h after acute exposure to
doxorubicin. We demonstrate a signiﬁcant improvement in cardiomyocyte viability when
grown in a 3D tri-culture environment over a 5-day period and a 10-fold reduction in
doxorubicin-induced toxicity. Our tri-culture model can be used as a valuable tool for phys-
iologically relevant assessment of drug-induced cardiotoxicity in vitro.
Introduction
Doxorubicin is a widely used chemotherapeutic agent
but has long been associated with cardiac dysfunction
in cancer patients (Bartlett et al., 2017). Doxorubicin
acts directly on cardiomyocytes (CMCs), generating re-
active oxygen species and reactive nitrogen species
(Cappetta et al., 2017). These moieties can result in
the upregulation of inﬂammatorymarkers, the induction
of apoptosis, and dysregulation of lysosomal autophagy,
eventually leading to cardiomyopathy and heart failure†Authors contributed equally.
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(Bartlett et al., 2017; Cappetta et al., 2017; Zhao &
Zhang, 2017). Understanding the “ﬁrst dose” acute ef-
fects of doxorubicin is critical to monitoring later events
associatedwith its cardiotoxicity, because even very low
doses have been associated with subclinical toxicity in
childhood cancer (Leger et al., 2015).
There have been a number of approaches to assess
cardiotoxicity; however, existing in vitro toxicity assays
that normally involve the culture of isolated CMCs alone
do not mimic the complexity of the physiologically dy-
namic environment (Kirkpatrick et al., 2007; Chaudhari
et al., 2018). Furthermore, determining safe dosages
has relied heavily on experimental animalmodels,where
precise mechanisms are difﬁcult to ascertain due to
interactingmolecular pathways in vivo. In addition, ﬁnd-
ings from animal studies are often not representative of
the outcomes in human subjects and are associated with
higher costs, technical demands, and ethical issues (U.K.
Government, 22 Oct. 2015; Novakovic et al., 2014).
Within cardiac tissue, CMCs exist along with other
cells, including endothelial cells (ECs), smooth muscle
cells (SMCs), ﬁbroblasts, and macrophages (Azzawi
et al., 1997), responding to cues from the extracellular
matrix and the surrounding cells (Bartlett et al., 2017;
Zhang & Shah, 2014). CMCs form the bulk of the myocar-
dial tissue, supplied by a rich network of blood vessels
and capillaries, such that ECs, SMCs, and CMCs lie in very
close proximity to each other. Despite their challenges,
recent studies have suggested that culturing CMCs with
other cell types in a 3D environment improves their sur-
vival, biochemical, and physiological responses, including
the ability to retain their contractile properties (Chan
et al., 2015; Narmoneva et al., 2004) and their spatial or-
ganisation in a 3D conﬁguration (Narmoneva et al., 2004).
In order to reproduce a 3D environment, investiga-
tors have used a range of strategies to host the cells,
from matrigel discs, simple spheroids, to scaffold bio-
material structures (Pononchuk et al., 2017; Roth &
Singer, 2014). The scaffolds can be synthesised using
synthetic (such as polyesters and poly (vinyl alcohol)
(PVA)), natural (such as collagen and gelatine), or a
blend of both types of material (reviewed in Novakovic
et al., 2014). Electrospinning technology enables the
fabrication of nanostructured scaffolds with complex
porous architecture resembling the extracellular ma-
trix. With the use of appropriate polymers, these con-
structs can replicate the biomechanical and structural
properties of native tissue, providing support and high
surface area for cell attachment, proliferation, and dif-
ferentiation (Sill & von Recum, 2008). The maintenance
of cell seeded scaffolds under ﬂow conditions also en-
ables the replication of mechanical forces (shear stress)
imparted on cells by ﬂowing interstitial ﬂuid
(Nithiananthan et al., 2017).
In the present study, we report the fabrication of a
3D PVA-gelatin nano-ﬁbrous scaffold, which is used to
seed CMCs, in tri-culture with ECs and SMCs, under
dynamic nutrient ﬂow, using the Quasi Vivo® system
(Pagliari et al., 2014). The construct is used to analyze
the effects of the common cardiotoxic drug doxorubi-
cin, integrating biophysical variables to mimic the
physiological state and provide efﬁcient and accurate
drug toxicity screening. Such a system has a strong
translational potential and can be used for screening
applications in preclinical drug development. Further-
more, we used a novel biosensor-based, highly sensitive
assay to assess the levels of the biomarker cardiac
Troponin I (cTnI) for doxorubicin toxicity (Atas et al.,
2015; Thygesen et al., 2012).
Methods
Materials
Human primary cells were purchased from suppliers
as follows: Primary human CMCs (PromoCell, GmbH),
human coronary artery ECs (PromoCell, GmbH), and
human coronary artery SMCs (Cellworks, UK). For each
cell type, their respective media was purchased from
the same supplier. They are all supplemented with foe-
tal calf serum (0.05 mL/mL) and growth factors, includ-
ing basic ﬁbroblast growth factor (10 ng/mL) and
epidermal growth factor (5 ng/mL). The EC culture me-
dia is additionally supplemented with vascular endothe-
lial growth factor (0.5 ng/mL). Full details are provided
by the respective suppliers. Other reagents and mate-
rials were supplied as indicated in each section below.
Flow chamber set-up
A bespoke perfusion bioreactor chamber (Quasi Vivo®,
Kirkstall Ltd., UK) was used for the experiments
(Pagliari et al., 2014). The chambers were intercon-
nected in series, using tubing, linked to a reservoir bot-
tle. Perfusion of the circulating media was supplied by a
peristaltic pneumatic micro-pump (Parker PF22x0103)
to provide constant recirculation under ﬂow conditions
(Vinci et al., 2011), (Fig. 1).
Scaffold synthesis and characterisation
Scaffolds were synthesised using the electrospinning
process, at room temperature and normal atmospheric
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humidity. PVA (99% hydrolyzed, M.Wt. 89,000–
98,000 gm/mol; Sigma Aldrich, UK) solution 12.5% w/v
in deionised water was mixed with Gelatine Type A
(Ge; approx. 300 Bloom; Aldrich Chemical Co., UK),
12.5% w/v in Acetic Acid:water, at a ratio 2:8 (PVA:
Ge). The electrospinning process was carried out at
16 kV and a ﬂow rate of 1 mL/h. The needle gauge
was 18G, and tip to collector distance was 15 cm. The
synthesised scaffolds were allowed to dry overnight to
ensure evaporation of residual solvents, then cross-
linked with methanol and stored in a sterile container.
Fibre diameter and orientation was determined using
scanning electron microscopy. Samples were washed
in PSS, then ﬁxed overnight in 2.5% glutaraldehyde,
followed by dehydration in serial alcohol and drying
using a vacuum desiccator. Samples were then sputter
coated with gold palladium and observed using the
Zeiss scanning electron microscope (Zeiss Supra™ 40VP).
Cell culture
Cells were cultured in a humidiﬁed atmosphere of 5%
CO2, 95% air, at 37°C, in their respective media, as rec-
ommended by the supplier. The cells were maintained
at low passage (<8), and the media changed every 2 to
3 days. When cells were ~80% conﬂuent, they were en-
zymatically passaged using TrypLE express reagent
(Thermo ﬁsher scientiﬁc, UK) and frequently
characterised to conﬁrm their phenotype. CMCs, ECs,
and SMCs were tagged using CellTracker™ blue, green,
and red (Invitrogen, UK), respectively. For the tri-
culture cells were grown (1:1:1) at the same seeding
density (3.33 × 103 cells/mL) on either a 2D TCPS
tissue-culture polystyrene coverslip (11 mm2 diameter;
Nunc, UK, incubated in human ﬁbronectin (Sigma
Aldrich) at 50 μg/mL prior to use) or on a 3D scaffold.
Electrospun 3D scaffolds were cut into discs of 2 mm
thickness and sterilised using a UV steriliser. Cell seeded
scaffolds or cells-coverslip constructs were placed ei-
ther in the perfusion chamber or in a 24-well plate and
held down using CellCrown™ 24 (Scaffdex, Finland).
The media was used at 1:1:1 proportion of the cell’s re-
spective medium. The biochemical composition of the
individual and mixed media was initially assessed using
the Stat Proﬁle Prime (Nova Biomedical, UK) media pro-
ﬁler. While there was a small increase in glucose levels
over the 5-day period of the mixed media, there was
no overall difference in composition and all the values
were within the physiological range (Fig. 2). Cells were
maintained either in either static conditions or under
ﬂow (at 50 μl/min) conditions. Once the cells reached
80% conﬂuency, they were maintained at 37°C (4%
CO2; 95% humidity) over a 5-day period.
Cells were identiﬁed using cell trackers and quanti-
ﬁed using live-dead reagent. Brieﬂy, the samples were
washed for 5 min in phosphate buffered solution (PBS)
and incubated in a solution of 2-μM calcein-AM (live)
and 4-μM ethidium homodimer-1 (dead) solution in
PBS for 30 min. After rinsing, the samples were imaged
with an inverted ﬂuorescence microscope (Leica
DMI6000B; Leica Microsystems, Germany) using a con-
ventional ﬂuorescein long pass ﬁlter. The quantiﬁcation
of the cells was done with Image J software (US Na-
tional Institutes of Health). At each time interval
analysed, images were taken from ﬁve random ﬁelds
per slide, for at least three slides. Cells numbers were
expressed per ﬁeld of view (FOV = 1 mm2). Cells were
ﬁxed in 10% neutral buffered formalin, rinsed in PBS,
and observed using the ﬂuorescent microscope (Leica
microsystem, UK). Cells were stained using anti-smooth
muscle actin and DAPI (nucleus).
Doxorubicin challenge
Cells were cultured for 5 days, then challenged with
doxorubicin (Sigma Aldrich; 0.01 nM to 100 μM) over a
2-h acute exposure period. Cell viability was assessed
using Alamar blue (AB) reagent according to the manu-
facturer’s instructions (Thermo ﬁsher, UK). AB is a sen-
sitive metabolic assay based on the reduction of
Figure 1. Schematic sketch of the Quasi Vivo ﬂow perfusion chamber set-up (A), with illustration of the chamber including cells seeded
within the scaffold (B).
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resazurin (blue) to the highly ﬂuorescent resoruﬁn (red)
inside metabolically active cells only. Hence, it is used
as a measure of cellular health and viability and has
been widely used to assess cell cytotoxicity in a range
of biological applications (Rampersad, 2012). Brieﬂy,
cells were rinsed in PBS and 100 μl of diluted AB reagent
(1:10 in medium) added to each well and incubated
over 4 h in the incubator at 37°C (protected from light).
AB ﬂuorescence was quantiﬁed in a microplate reader
(excitation wavelength 530 nm; emission wavelength
590 nm) (Molecular Devices, Menlo Park, CA, USA).
The background ﬂuorescence of media alone (plus AB
reagent) was subtracted in the analysis. Cells treated
with 2% Triton X-100 was included in each assay as a
control. Displayed results are from three independent
experiments carried out in triplicates.
Measurement of nitric oxide levels
To measure the nitric oxide (NO) levels, cultured cells
were exposed to the agonist acetylcholine (ACh,
0.01 μM) for 0–30 min and NO was quantiﬁed using the
Griess reaction. Brieﬂy, equal volumes of sample and
Griess reagent (1% sulfanilamide in 2.5% H3PO4 and
0.1% N-(1-naphthyl) ethylenediamine dihydrochloride)
were incubated at room temperature for 10 min. The
absorbance was measured at 570 nm using the micro-
plate reader. The content of nitrite was calculated
based on a standard curve constructed with NaNO2
(3.12 to 400 μM). The assay sensitivity is approximately
125 pMoL (Gómez et al., 2013).
Troponin I levels
Cardiac troponin I (cTnI) levels in culture medium
was detected and analysed by Elisha Systems Ltd
(Wakeﬁeld, UK), using novel biosensors based on com-
mercially available dual electrodes and an immobilised
polyclonal antibody against Troponin-I. Polyclonal rab-
bit anti-Troponin-I (Raybiotech, Rabbit anti-Troponin)
was diluted in phosphate buffer pH 7.0 and immobilised
using a proprietary method to allow antibody proximity
Figure 2. Biochemical composition of the culture media using the media proﬁler. The composition of the individual media for the respec-
tive cell types (Cardiomyocytes (CMCs, A), smooth muscle cells (SMCs, B), endothelial cells (ECs, C)), as well as the mixed media for their
tri-culture (D), was determined over a 3-day period. All biochemical indices were within the physiological ranges for Sodium (Na,
100–180 mmol/L); partial pressure of oxygen (pO2, 5–800 mmHg); partial pressure of carbon dioxide (pCO2, 5–130 mmHg); chloride (Cl,
65–140 mmol/L); pH (6.5–8.2); ionised calcium (iCa, 0.25–2.5 mmol/L); potassium (K, 2.0–9.0 mmol/L); glucose (Glu, 1.1–38.9 mmol/L);
lactate (Lac, 0.3–20.0 mmol/L); bicarbonate (HCO3, 1.0–85.0 mmol/L); total CO2 or bicarbonate (TCO2, 5.0–50.0 mmol/L). CMC, cardio-
myocyte; EC, endothelial cell; SMC, smooth muscle cell.
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to the surface of working electrode 2 of a dual gold
electrode (DropSens Dual customised gold electrode
Ref. CX2220AT). A polyclonal sheep anti-digoxin (pre-
pared in-house) was used as the non-speciﬁc internal
control immobilised onto working electrode 1. Solu-
tions of Troponin-I in culture medium were used to
calibrate the biosensors. Samples were analysed by ex-
posing the upper surfaces of the biosensors to 30 μl of
sample, incubating for 5 min, then rinsing with 10×
PBS. Biosensors were then connected to a SP200
BioLogic potentiostat with an integral AC impedance
monitor. Impedance of the surfaces were measured
over a frequency range of 1–1000 Hz in a 10 mM
Ferricyanide/Ferrocyanide PBS (10×) solution. Total im-
pedance values at 1 Hz were used to generate the
graphical data, correcting for non-speciﬁc binding by
Figure 3. Establishing a tri-culture of cells in static conditions. (A) Light micrograph images of isolated cells after 5 days in 2D culture in
static conditions. Cardiomyocytes (CMCs) (a), smooth muscle cells (SMCs) (b), and Endothelial cells (ECs) (c), in monoculture were stained
blue (DAPI, nuclear stain); and red (F-actin Phalloidin, cytoskeletal stain). A bright ﬁeld image of all three cell types in tri-culture (d), and
the image of the ﬂuorescently tagged cells (e) is merged in ﬁgure (f) (CMCs blue; SMCs red; ECs green). Scale bar 100 μm. (B) Cell survival
in monoculture and tri-culture conditions. The total number of CMCs, SMCs, and ECs grown after 1, 3, and 5 days, in isolation (monocul-
ture) or in combination (tri-culture), under 2D static conditions. $P < 0.05; #P < 0.01; *P < 0.001; **P < 0.0001.
Cardiomyocytes in a Tri-Culture Model System Eliesmaziah Alias et al.
2018 | Volume 3 | Issue 3 |
Page 126
subtracting the impedance values of working electrode
1 from those of working electrode 2 and converting to
percentage impedance change to normalise the data.
Results from several biosensors were pooled to give an
overall average response. Internal software algorithms
were used to calculate standard deviation, standard er-
rors, and percentage variability of the coefﬁcient of
variation (CV%). Coefﬁcient of variation values accept-
able for the assay were ±15%.
Data analysis
Repeated measures analysis of variance and student’s t
test were used to assess statistical signiﬁcance, using
IBM SPSS. Values of P < 0.05 were considered signiﬁ-
cant. Data are presented as mean ± standard error of
mean. The half maximal inhibition concentration
(IC50; 50% of growth inhibition) was calculated using
Origin Lab software.
Results
Establishing a dynamic tri-culture of cardiac
cells
Tri-culture of cells in a 2D environment
In a 2D culture on coverslips, all cell types grew to
conﬂuency. At early time points, cells grew in themiddle
where they were initially seeded and later spread to the
periphery over time. We demonstrate cell survival in
monoculture and tri-culture for all three cell types
(Fig. 3A), as can be seen by the formation of an intense
meshwork of cellular connections in the tri-culture
system. We then quantiﬁed the cell numbers over the
5-day incubation period and found that while the SMC
numbers were maintained at a relatively constant level,
the CMC and EC numbers increased signiﬁcantly in the
tri-culture system when compared with the monocul-
ture system (signiﬁcantly higher numbers for ECs on
day 3; twofold and 10-fold increase in CMC and EC num-
bers in tri-culture, respectively; P < 0.0001) (Fig. 3B).
Physiological responsiveness of endothelial cells un-
der static and ﬂow conditions
Subsequently, the physiological responsiveness of ECs
was assessed. The cells were grown over 5 days and
then challenged with Ach, at a concentration of
0.01 μM (established as the maximal concentration to
provide vasodilator responses ex vivo over a 30-min pe-
riod) (Mohamed et al., 2017). A small non-signiﬁcant in-
crease in NO levels after 20 min of exposure to the
agonist for both mono and tri-culture models was ob-
served (Fig. 4). In a separate set of experiments, cells
were cultured under ﬂow conditions at 50 μl/min. Un-
der ﬂow conditions, cell numbers for each cell type
were maintained and the morphology of the cells was
elongated, when compared with a spherical morphol-
ogy for cells cultured under static conditions. Further-
more, we observed a signiﬁcant increase in CMC cell
number after 5 days of culture, both under static condi-
tions and ﬂow conditions. SMC and EC numbers were
signiﬁcantly increased after 5 days under ﬂow condi-
tions (Fig. 5A, B).
Establishment of the 3D cell culture system
For the 3D cell culture, PVA-gelatine nanostructured 3D
scaffolds were initially fabricated and characterised.
The ﬁbre diameter ranged from 160–300 nm, and the
scanning electron microscopy images of the scaffold in-
dicated overlapping ﬁbres without any speciﬁc orienta-
tion (Fig. 6). The fabricated 3D scaffolds promoted CMC
cell growth and attachment (Fig. 6, inset).
Cellular responses to acute doxorubicin
exposure
A tri-culture model of cardiomyocytes protects
against doxorubicin-induced cardiomyocyte toxicity
At the start of each experiment, in the absence of
doxorubicin exposure, viability of all cell types was
>99%. As expected, acute exposure to doxorubicin re-
sulted in a dose-dependent reduction in CMC cell viabil-
ity when these cells were cultured in isolation, in both
2D and 3D environments, under static conditions
(Fig. 7A). However, when CMCs were grown in tri-
Figure 4. Physiological responsiveness of ECs in cell culture. Cells
were cultured for a period of 5 days and then challenged with Ach
(0.01 μM) in monoculture and tri-culture, in a 2D culture system
under static conditions. EC, endothelial cell.
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culture, along with SMCs and ECs under static condi-
tions, the toxicity of doxorubicin, hence the dose-
dependent reduction in viability, was markedly reduced
by approximately a factor of 10. Hence, there was a
10-fold reduction in IC50 values (IC50 in 2D: 0.65 and
0.085 nM for in monoculture and tri-culture, respec-
tively; IC50 in 3D: 5.43 and 0.32 nM in monoculture
and tri-culture, respectively (Fig. 7A)).
We next assessed the effect of doxorubicin toxicity
on CMC viability for cells cultured under ﬂow
conditions. While the doxorubicin-induced toxicity
was dose-dependent, as under static conditions, cells
cultured under ﬂow conditions showed reduced toxicity
to doxorubicin in comparison with the static culture
model, for both the 2D culture system and the 3D cul-
ture system. The IC50 values showed a marked reduc-
tion (by approximately 10-fold) from 7.46 to 0.92 nM;
and from 41 nM down to 2.7 nM, in 3D and 2D culture,
respectively. Doxorubicin toxicity was minimal for the
tri-culture 3D system under ﬂow conditions (Fig. 7B).
Figure 5. Establishing a dynamic tri-culture of cells. (A) Light microscopy images of cells isolated after 5 days in 2D culture under ﬂow
conditions. CMCs (a), SMCs (b), and ECs (c), in tri-culture (d, merged) are ﬂuorescently tagged (CMCs blue; SMCs red; ECs green). (B) Cell
survival under ﬂow conditions. The total number of ECs, CMCs, and SMCs grown after 1, 3, and 5 days, under 2D static and ﬂow conditions.
CMC, cardiomyocyte; EC, endothelial cell; SMC, smooth muscle cell.
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Endothelial cells are protective against
doxorubicin-induced cardiomyocyte toxicity
All cell types were exposed to doxorubicin, in isolation,
and in tri-culture, in 2D and 3D (Fig. 7C and D, respec-
tively). In order to assess the protective effect of ECs
on CMCs, CMCs were grown in co-culture with ECs,
and the response to doxorubicin-induced toxicity was
assessed in 2D (Fig. 7C) and 3D (Fig. 7D). Initially, in
the absence of doxorubicin exposure, viability for all
cell types was >99%. Doxorubicin toxicity to CMCs was
reduced when they were co-cultured in the presence
of ECs (IC50 values were 0.92 nM vs. 8.4 nM and
2.7 nM vs. 39.8 nM for CMCs alone vs. CMCs co-cultured
with ECs, respectively). Analysis of samples (from both
CMC monoculture and tri-culture) for cTnI levels using
the biosensors demonstrated higher levels of cTnI in
the monoculture than in the tri-culture (averaged at
7.60 and 3.89 pg/mL after doxorubicin challenge, vs.
0.32 and 0.00 pg/mL in the absence of doxorubicin, in
monoculture and tri-culture, respectively; calculated
from normalised data) (Fig. 8A, B).
Discussion
It is important that in vitro models recapitulate in vivo
physiological conditions when studying the effects of
drugs on the cell environment and cell functionality,
in order to be used in translational medicine. In the
present study, we describe the development and char-
acterisation of a 3D cell culture system for CMCs, tri-
cultured in the presence of other cell types such as
the ECs and the SMCs that have the ability to form a
Figure 6. Fabrication of 3D scaffolds using electrospinning. Fibre
diameter frequency and scanning electron microscopy image in
the absence and presence of seeded cells (upper and lower inset),
after a 5-day culture.
Figure 7. Cellular responses to acute doxorubicin exposure. CMC viability in monoculture and tri-culture, under static (A) and ﬂow (B)
conditions. Least toxicity was achieved for tri-cultured cells, under ﬂow conditions, in the 3D environment. Cell viability for all cardiac
cells in monoculture and tri-culture under ﬂow conditions is compared in 2D (C) and 3D (D) environments. CMC, cardiomyocyte; EC, en-
dothelial cell; SMC, smooth muscle cell.
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3D matrix that closely resembles the in vivo environ-
ment. In this tri-culture model, we demonstrate that
CMCs grown with ECs and SMCs show reduced
doxorubicin-induced cardiotoxicity, in comparison with
their growth in monoculture. Furthermore, under ﬂow
conditions that model the shear stress in vivo, we show
a further reduction in doxorubicin-induced toxicity
against CMCs.
We demonstrate that the maintenance of CMCs in tri-
culture supports their viability over a period of 5 days.
This is also observed for ECs, which maintain their phys-
iological responsiveness to agonist stimulation in tri-
culture, as shown by maximal NO levels, 20 min after
ACh challenge. Nitrite levels were within the nM range
for all time points, which is well within the assay sensi-
tivity used in the present study (Gómez et al., 2013).
Although ECs are the classic cell type associated with
NO release, a key cardiovascular signalling molecule,
eNOS is also associated with caveoli structures within
the plasma membrane of SMCs and CMCs; hence, their
NO contribution cannot be excluded (Zhang & Shah,
2014; Bernhardt et al., 1991). Using a milli-ﬂuidic sys-
tem, cells were subjected to physiological rates of in-
terstitial ﬂuid ﬂow (5.59 × 104 dyn/cm2) (Sill & von
Recum, 2008; Mazzei et al., 2010; Kang et al., 2017;
Rashidi et al., 2016) and grown within a nanostructured
scaffold that did not adversly affect cell attachment
and viability.
We further demonstrate the dose-dependent reduc-
tion in doxorubicin-induced CMC toxicity when tri-
cultured with ECs and SMCs, in particular when grown
under ﬂow conditions, in a 3D environment. While the
dose-dependent cumulative toxicity of doxorubicin is
well documented for CMCs, we also demonstrate a sig-
niﬁcant dose-dependent reduction in EC and SMC num-
bers (Wojcik et al., 2015; Bielak-Zmijewska et al.,
2014). Doxorubicin-induced EC apoptosis and disturbed
crosstalk between ECs and CMCs has recently been
demonstrated using VEGF-B gene therapy in a murine
model (Rasanen et al., 2016). NO from ECs plays a pro-
tective role in CMCs from doxorubicin, probably via
eNOS uncoupling. The exposure to doxorubicin has
been shown to increase the expression and protein ac-
tivity of eNOS (Kalivendi et al., 2001). Others have also
shown the protective effects of ECs as a result of fac-
tors such as Neuregulin-1 when adjacent to CMCs
(Lemmens et al., 2006). Furthermore, ECs line the cor-
onary vasculature and play an important role in diame-
ter regulation and homeostasis through the release of
mediators, including NO. Importantly, they form a se-
lective barrier between the myocardium and the circu-
lating blood, regulating the exchange of oxygen and
nutrients. Wilkinson et al. (2016) have demonstrated
that doxorubicin can inhibit EC–cell tight junction for-
mation resulting in increased drug permeability.
Hence, it is plausible that the protective effect of ECs
in our study is mediated by the barrier function of ECs
by minimising the exposure of CMCs to doxorubicin.
This, however, needs to be conﬁrmed by analysing
the organisational structure of CMCs and ECs in a
co-culture system. Other cell types within the myocar-
dium may also inﬂuence doxorubicin toxicity. For ex-
ample, in a cardiac spheroid model, Pononchuk et al.
(2017) have highlighted important crosstalk between
ﬁbroblasts, CMCs, and ECs. While NO released from
ECs protects CMCs against doxorubicin-induced apopto-
sis, doxorubicin induces reactive oxygen species pro-
duction and eNOS over-expression in cardiac
ﬁbroblasts, leading to peroxynitrous acid formation,
which can override the protective effects of co-cultured
ECs (Pononchuk et al., 2017). Within our tri-culture
system, the speciﬁc role of the SMCs in inﬂuencing
Figure 8. Detection of cTnI levels using biosensors. cTnI levels demonstrate higher levels of cTnI in monoculture (A) than in tri-culture (B),
using novel biosensor technology.
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doxorubicin-induced CMC-toxicity requires further in-
vestigation, by also assessing apoptotic cell death, as
an important parameter in doxorubicin toxicity, for
all cell types. Furthermore, possible variation in expo-
sure conditions and uptake kinetics of drugs and re-
agents between 2D and 3D culture cannot be excluded
as a contributing factor to the observed reduced
doxorubicin-induced toxicity in our 3D environment
(Casey et al., 2016).
The concentration ranges of doxorubicin used in the
present study are within the ranges that the cells are
exposed to in vivo (Gunven et al., 1986; Barpe et al.,
2010). For example, in normal weight patients, infusion
of 60 mg/m2 of doxorubicin led to peak plasma concen-
trations of 630.4 ± 22.1 ng/mL within 0.66 h, reducing
to 39.8 ± 15.3 ng/mL after 24.66 h after infusion (Barpe
et al., 2010). This equates to 315 and 20 nM, respec-
tively, which is within the wide range used herein
(0.01 nM to 100 μM). Furthermore, the documented in-
tracellular concentration of doxorubicin within tumour
cells range from 0.007 to 0.013 nmol/mg protein and
0.027 to 0.086 nmol/mg protein, before and after con-
comitant therapy with verapamil and cyclosporine
(Tidefelt et al., 1994).
We detected cTnI levels as an indicator of cell toxic-
ity within the cell seeded PVA-gelatin scaffolds. cTnI is
a predictive “gold standard” biomarker for cardiac in-
jury (Atas et al., 2015) and myocardial infarction
(Thygesen et al., 2012) with high myocardial tissue
speciﬁcity and clinical sensitivity. cTnI has previously
been assayed using commercial ELISA kits with a lower
limit of detection of 1 ng/mL (Atas et al., 2015). We
used a state-of-the-art assay for sensitive and speciﬁc
cTnI detection using robust biosensors with a detection
levels in pico molar range. CMCs grown in monoculture
had elevated levels of cTnI, which were reduced as the
cells were cultured in a tri-culture system, indicating
that the presence of ECs and SMCs has a protective ef-
fect on CMCs. We also detected negligible levels of cTnI
in the absence of doxorubicin exposure, and we postu-
late that this low concentration of cTnI is released by
CMCs as an intact protein as a result of stretch-related
mechanism mediated by integrin molecules (Hessel
et al., 2008).
In conclusion, we utilised a novel tri-culture dynamic
system to demonstrate a protective role for ECs against
doxorubicin-induced CMC toxicity. Our model is an
attractive non-animal alternative approach to drug
testing and assessing new cardio protective strategies
against doxorubicin toxicity.
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